420
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 699-706 | Received 28 Apr 2023, Accepted 17 Jul 2023, Published online: 18 Jul 2023